|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,409.00 JPY | +0.15% |
|
-0.90% | +19.99% |
| 03-04 | Nxera Pharma Co., Ltd. Submits Marketing Authorization Application For Daridorexant In South Korea | CI |
| 03-04 | Nxera Submits South Korea Filing for Insomnia Drug Daridorexant | MT |
MarketScreener Editorial Features
Search
| At the foot of Mount Fuji, three champions carry Takaichi's ambition | February 19, 2026 at 05:36 am | |
![]() | Shionogi strengthens position by acquiring Torii | September 17, 2025 at 06:18 am |
| Global markets live: Apple, 3M Company, Boeing, Honeywell... | July 29, 2024 at 11:11 am | |
![]() | The market is still looking for an inflection point | December 12, 2022 at 12:02 pm |
![]() | New entries in the Asia Investor Portfolio | December 07, 2022 at 05:26 am |
![]() | New week of gains for our 3 selections | December 05, 2022 at 12:45 pm |
| Global markets live: LVMH, GSK, Twitter, Blackrock, Walmart... | April 13, 2022 at 12:17 pm | |
![]() | New purchases in the MarketScreener Asia Portfolio | March 15, 2022 at 09:34 am |
![]() | MarketScreener's World Press Review : February 25, 2022 | February 25, 2022 at 08:28 am |
![]() | PUMP / DUMP #20: This week's gainers and losers | February 04, 2022 at 11:48 am |
![]() | MarketScreener’s World Press Review : December 21, 2021 | December 21, 2021 at 06:26 am |
No results for this search
- Stock Market
- Equities
- 4507 Stock
- News Shionogi & Co., Ltd.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition





















